Tysabri patient-reported outcomes research program in MS

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Tysabri patient-reported outcomes research program in MS

Postby MSUK » Fri Jun 11, 2010 1:33 am

Tysabri patient-reported outcomes research program in MS announced

Image

Biogen Idec and Elan Corporation, plc, in collaboration with EPI-Q, Inc. and Avatar International, LLC, have announced the launch of My MS Health, a first-of-its-kind, web-based, patient-reported outcomes (PRO) research program.

My MS Health is designed to track and provide instant reports on patient function and quality of life (QoL) using validated measures over time. This outcomes research program will assess the impact of using My MS Health on patient-healthcare provider communication, and was developed with guidance from a multidisciplinary steering committee of individuals from healthcare and patient communities, as well as academia.

Interested patients and healthcare providers who meet the research criteria can register for the program at http://www.mymshealth.org/ .... Read More -
http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1905
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2123
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service